Pediatric bronchogenic cyst complicated by atypical mycobacterium infection: a case report

Stacy A Frye1, James M Decou

  • 1Grand Rapids Medical Education Center Pediatric Residency Program, Michigan State University, Helen DeVos Children’s Hospital,330 Barclay Avenue NE, Suite 300, Grand Rapids, MI 49503, USA. stacyfrye@gmail.com

Cases Journal
|November 18, 2009
PubMed

Insights

Bronchogenic cysts, common in children, can rarely be infected by atypical mycobacteria. Early diagnosis and treatment with surgery and antibiotics are crucial for successful outcomes in pediatric patients.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Congenital Abnormalities

Background:

  • Bronchogenic cysts are congenital mediastinal lesions originating from the foregut.
  • They typically present as unilocular cysts with clear fluid.
  • Respiratory distress is common in pediatric cases, marked by cough, stridor, wheezing, and retractions.

Observation:

  • This report details the first pediatric case of a bronchogenic cyst complicated by atypical Mycobacterium infection.
  • The patient was a 13-year-old female with a large, multilocular intraparenchymal cyst and extensive pulmonary involvement.
  • Pathology revealed necrotizing granulomatous inflammation and acid-fast bacilli.

Findings:

  • Successful treatment involved surgical excision and a six-week course of clarithromycin, rifampin, and ethambutol.
  • Unusual features included multilocular appearance, turbid cyst drainage, and late symptom onset.
  • Acid-fast stains on resected cyst specimens are vital due to frequent negative cultures.

Implications:

  • Bronchogenic cyst should be considered in pediatric differential diagnoses for cough, dyspnea, and fever.
  • Mycobacterial infection must be considered in pediatric bronchogenic cysts, especially when infected.
  • Surgical excision is recommended for symptomatic or enlarging cysts, with prophylactic removal advised for asymptomatic ones.
Abstract

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...